GIP and breast carcinoma: GIP is effective in animal studies in nine types of cancers, including in MCF-7 estrogen-dependent breast cancer (50% to 80% reduction in growth) and slightly less in MDA-MB-231 estrogen-independent breast cancer (where it reduces its growth by 40%) [21,25,26].